June 16, 2022
The Emory Healthcare Student Loan Repayment Benefit provides employees with a monthly $100 loan payment to help reduce, and ultimately eliminate, student loan debt.
ATLANTA – In an effort to help employees with student loan debt, Emory Healthcare launched a new student loan repayment benefit on June 15, 2022.
Emory Healthcare employees who are benefits-eligible and have been employed for 90 days can take advantage of this new program. Employees can receive a $100 monthly loan payment (up to $1,200 a year), sent directly to their student loan account servicer, with the first tax-free contribution occurring in July. These additional payments will help reduce the length of the employee’s student loan.
“We are excited to offer this new loan repayment benefit option to assist in our valued employees’ journey to financial student loan freedom,” says Lilicia Bailey, chief human resources officer for Emory Healthcare. “This new benefit adds to a wide array of options offered to our team members to support growth, well-being and ease of financial stress.”
Emory Healthcare is collaborating with Tuition.io, an educational assistance benefits platform, to offer the program.
When enrolling with Tuition.io, employees will have access to a full suite of tools to help manage and, over time, eliminate student loan debt. Resources include: one-on-one student loan coaching, a marketplace for refinancing existing student loans and information and assistance with loan forgiveness programs.
The program can also help prepare with future college financing. If employees are parents of college-bound children, Tuition.io will help find ways to save and pay for their education, as well.
“Relieving the heavy burden of student loan debt can help our employees focus on the future,” says Bailey.
The Emory Healthcare Student Loan Repayment Benefit has a $10,000 lifetime cap per employee. Eligible student loans must be in the employee’s name and must have been used for the employee’s education purposes only.
By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-NoDerivatives 4.0 International Public License (“Public License”). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.
Section 1 – Definitions.
Section 2 – Scope.
Section 3 – License Conditions.
Your exercise of the Licensed Rights is expressly made subject to the following conditions.
If You Share the Licensed Material, You must:
Section 4 – Sui Generis Database Rights.
Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:
Section 5 – Disclaimer of Warranties and Limitation of Liability.
Section 6 – Term and Termination.
Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:
Section 7 – Other Terms and Conditions.
Section 8 – Interpretation.
Creative Commons is not a party to its public licenses. Notwithstanding, Creative Commons may elect to apply one of its public licenses to material it publishes and in those instances will be considered the “Licensor.” The text of the Creative Commons public licenses is dedicated to the public domain under the CC0 Public Domain Dedication. Except for the limited purpose of indicating that material is shared under a Creative Commons public license or as otherwise permitted by the Creative Commons policies published at creativecommons.org/policies, Creative Commons does not authorize the use of the trademark “Creative Commons” or any other trademark or logo of Creative Commons without its prior written consent including, without limitation, in connection with any unauthorized modifications to any of its public licenses or any other arrangements, understandings, or agreements concerning use of licensed material. For the avoidance of doubt, this paragraph does not form part of the public licenses.